FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2568435816> ?p ?o ?g. }

• W2568435816 endingPage "1040" @default.
• W2568435816 startingPage "1030" @default.
• W2568435816 abstract "Type 2 diabetes mellitus (T2DM) is a well-recognized independent risk factor for heart failure. T2DM is associated with altered cardiac energy metabolism, leading to ectopic lipid accumulation and glucose overload, the exact contribution of these two parameters remaining unclear. To provide new insight into the mechanism driving the development of diabetic cardiomyopathy, we studied a unique model of T2DM: lipodystrophic Bscl2−/− (seipin knockout [SKO]) mice. Echocardiography and cardiac magnetic resonance imaging revealed hypertrophic cardiomyopathy with left ventricular dysfunction in SKO mice, and these two abnormalities were strongly correlated with hyperglycemia. Surprisingly, neither intramyocardial lipid accumulation nor lipotoxic hallmarks were detected in SKO mice. [18F]Fludeoxyglucose positron emission tomography showed increased myocardial glucose uptake. Consistently, the O-GlcNAcylated protein levels were markedly increased in an SKO heart, suggesting a glucose overload. To test this hypothesis, we treated SKO mice with the hypoglycemic sodium–glucose cotransporter 2 (SGLT2) inhibitor dapagliflozin and the insulin sensitizer pioglitazone. Both treatments reduced the O-GlcNAcylated protein levels in SKO mice, and dapagliflozin successfully prevented the development of hypertrophic cardiomyopathy. Our data demonstrate that glucotoxicity by itself can trigger cardiac dysfunction and that a glucose-lowering agent can correct it. This result will contribute to better understanding of the potential cardiovascular benefits of SGLT2 inhibitors." @default.
• W2568435816 created "2017-01-13" @default.
• W2568435816 creator A5001127450 @default.
• W2568435816 creator A5001551018 @default.
• W2568435816 creator A5009182471 @default.
• W2568435816 creator A5021258982 @default.
• W2568435816 creator A5026080513 @default.
• W2568435816 creator A5028556868 @default.
• W2568435816 creator A5032392391 @default.
• W2568435816 creator A5037500178 @default.
• W2568435816 creator A5039422153 @default.
• W2568435816 creator A5053756068 @default.
• W2568435816 creator A5066137184 @default.
• W2568435816 creator A5069132423 @default.
• W2568435816 creator A5081536133 @default.
• W2568435816 creator A5084594045 @default.
• W2568435816 creator A5088183161 @default.
• W2568435816 date "2017-01-04" @default.
• W2568435816 modified "2023-10-17" @default.
• W2568435816 title "The Sodium–Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Cardiomyopathy in a Diabetic Lipodystrophic Mouse Model" @default.
• W2568435816 cites W1599819598 @default.
• W2568435816 cites W1971412377 @default.
• W2568435816 cites W1986276307 @default.
• W2568435816 cites W1989344342 @default.
• W2568435816 cites W1996539872 @default.
• W2568435816 cites W2014932253 @default.
• W2568435816 cites W2022143285 @default.
• W2568435816 cites W2041365735 @default.
• W2568435816 cites W2057561996 @default.
• W2568435816 cites W2058536977 @default.
• W2568435816 cites W2075358633 @default.
• W2568435816 cites W2078330387 @default.
• W2568435816 cites W2078633259 @default.
• W2568435816 cites W2110092749 @default.
• W2568435816 cites W2110217195 @default.
• W2568435816 cites W2127321192 @default.
• W2568435816 cites W2136238917 @default.
• W2568435816 cites W2144766505 @default.
• W2568435816 cites W2167251566 @default.
• W2568435816 cites W2168135465 @default.
• W2568435816 cites W2284080609 @default.
• W2568435816 cites W2296574982 @default.
• W2568435816 cites W2412800896 @default.
• W2568435816 cites W2417223785 @default.
• W2568435816 cites W2492672367 @default.
• W2568435816 cites W2913709946 @default.
• W2568435816 doi "https://doi.org/10.2337/db16-0733" @default.
• W2568435816 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28052965" @default.
• W2568435816 hasPublicationYear "2017" @default.
• W2568435816 type Work @default.
• W2568435816 sameAs 2568435816 @default.
• W2568435816 citedByCount "114" @default.
• W2568435816 countsByYear W25684358162017 @default.
• W2568435816 countsByYear W25684358162018 @default.
• W2568435816 countsByYear W25684358162019 @default.
• W2568435816 countsByYear W25684358162020 @default.
• W2568435816 countsByYear W25684358162021 @default.
• W2568435816 countsByYear W25684358162022 @default.
• W2568435816 countsByYear W25684358162023 @default.
• W2568435816 crossrefType "journal-article" @default.
• W2568435816 hasAuthorship W2568435816A5001127450 @default.
• W2568435816 hasAuthorship W2568435816A5001551018 @default.
• W2568435816 hasAuthorship W2568435816A5009182471 @default.
• W2568435816 hasAuthorship W2568435816A5021258982 @default.
• W2568435816 hasAuthorship W2568435816A5026080513 @default.
• W2568435816 hasAuthorship W2568435816A5028556868 @default.
• W2568435816 hasAuthorship W2568435816A5032392391 @default.
• W2568435816 hasAuthorship W2568435816A5037500178 @default.
• W2568435816 hasAuthorship W2568435816A5039422153 @default.
• W2568435816 hasAuthorship W2568435816A5053756068 @default.
• W2568435816 hasAuthorship W2568435816A5066137184 @default.
• W2568435816 hasAuthorship W2568435816A5069132423 @default.
• W2568435816 hasAuthorship W2568435816A5081536133 @default.
• W2568435816 hasAuthorship W2568435816A5084594045 @default.
• W2568435816 hasAuthorship W2568435816A5088183161 @default.
• W2568435816 hasBestOaLocation W25684358161 @default.
• W2568435816 hasConcept C126322002 @default.
• W2568435816 hasConcept C134018914 @default.
• W2568435816 hasConcept C2776553924 @default.
• W2568435816 hasConcept C2777391703 @default.
• W2568435816 hasConcept C2777422806 @default.
• W2568435816 hasConcept C2778198053 @default.
• W2568435816 hasConcept C2778797674 @default.
• W2568435816 hasConcept C2780185194 @default.
• W2568435816 hasConcept C2910068830 @default.
• W2568435816 hasConcept C44353895 @default.
• W2568435816 hasConcept C555293320 @default.
• W2568435816 hasConcept C71924100 @default.
• W2568435816 hasConceptScore W2568435816C126322002 @default.
• W2568435816 hasConceptScore W2568435816C134018914 @default.
• W2568435816 hasConceptScore W2568435816C2776553924 @default.
• W2568435816 hasConceptScore W2568435816C2777391703 @default.
• W2568435816 hasConceptScore W2568435816C2777422806 @default.
• W2568435816 hasConceptScore W2568435816C2778198053 @default.
• W2568435816 hasConceptScore W2568435816C2778797674 @default.
• W2568435816 hasConceptScore W2568435816C2780185194 @default.
• W2568435816 hasConceptScore W2568435816C2910068830 @default.
• W2568435816 hasConceptScore W2568435816C44353895 @default.

• next